Target intelligence / Profile preview

Ocular inflammation

01

Overview

Ocular inflammation is a broad clinical term encompassing various inflammatory conditions of the eye, including uveitis, scleritis, and keratitis (StatPearls, NBK532252). It is characterized by an immune response involving the infiltration of leukocytes and the production of pro-inflammatory cytokines such as TNF-alpha and various interleukins (PubMed, PMID: 30630136). This condition is not a single molecular target but a complex pathological state that can lead to significant morbidity, including permanent vision loss if not managed effectively (Mayo Clinic, 2023). Drugs used in this context, such as corticosteroids or biologics, act on specific molecular targets like the glucocorticoid receptor or specific cytokines rather than the condition itself (NIH/NEI, 2023). Therefore, ocular inflammation is considered a therapeutic indication or disease role rather than a discrete protein or receptor target.

Other names
UveitisScleritisIritisConjunctivitisKeratitisEndophthalmitisOcular inflammatory disease
02

Mechanism of action

Not applicable as this is a disease state or clinical condition rather than a specific molecular target.

03

Biological functions

Immune response
04

Disease associations

Inflammation
05

Safety considerations

Permanent vision lossSecondary glaucomaCataract formationCystoid macular edema
06

Biomarkers

C-reactive proteinAqueous humor cytokine levelsAnterior chamber cell countOptical coherence tomography (OCT) imaging

Beyond the preview

Go deeper on Ocular inflammation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular inflammation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call